miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1

Hui Gong1, Lishan Fang2, Yifan Li1

  • 1Central Laboratory, Shenzhen Nanshan People's Hospital/Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, Guangdong 518033, P.R. China.

Oncology Reports
|January 13, 2018
PubMed

Insights

MicroRNA-873 (miR-873) is decreased in colorectal cancer (CRC), suppressing tumor growth. Lower miR-873 levels correlate with advanced CRC and poorer survival, indicating its potential as a prognostic marker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-873 (miR-873) dysregulation is noted in various cancers.
  • The specific role and mechanism of miR-873 in colorectal cancer (CRC) are not well understood.

Purpose of the Study:

  • To investigate the biological function and molecular mechanism of miR-873 in CRC.
  • To determine if miR-873 can serve as a prognostic marker or therapeutic target for CRC.

Main Methods:

  • Quantitative analysis of miR-873 expression in CRC cell lines and patient tissues.
  • Correlation analysis between miR-873 levels and clinical parameters (disease stage, survival rates).
  • Functional assays (proliferation) and molecular mechanism studies (luciferase assays, target validation).

Main Results:

  • miR-873 expression was significantly reduced in CRC tissues and cell lines.
  • Lower miR-873 expression correlated inversely with CRC disease stage and predicted shorter patient survival.
  • miR-873 suppressed CRC cell proliferation by targeting tumor necrosis factor receptor-associated factor 5 (TRAF5) and MAP3K7 binding protein 1 (TAB1), thereby inhibiting nuclear factor κB (NF-κB) signaling.

Conclusions:

  • miR-873 acts as a tumor suppressor in CRC progression.
  • miR-873 holds potential as a novel prognostic biomarker and therapeutic target for colorectal cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K